Latest News about IONS
Recent news which mentions IONS
Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal
March 12, 2025
From Benzinga
What Analysts Are Saying About Ionis Pharmaceuticals Stock
March 11, 2025
Tickers
IONS
From Benzinga
What Analysts Are Saying About Ionis Pharmaceuticals Stock
February 20, 2025
Tickers
IONS
From Benzinga
Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales
February 19, 2025
From Benzinga
Earnings Scheduled For February 19, 2025
February 19, 2025
From Benzinga
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 5 Experts
January 15, 2025
Tickers
IONS
From Benzinga
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
January 07, 2025
From Benzinga
From Benzinga
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
December 20, 2024
Tickers
IONS
From Benzinga
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
December 20, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
From Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
From Benzinga
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 10, 2024
From Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
From Benzinga
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
August 26, 2024
Tickers
IONS
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
From Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
From Benzinga
From Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31, 2024
From Benzinga
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.